Insider Cluster (3 insiders) ·Filed Aug 10, 2026

TEVA

TEVA PHARMACEUTICAL INDUSTRIES LTD
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago
Insider cluster: 3 insiders, $1.3M total
Actionable Insight • Neutral

The insider selling is immaterial in dollar terms and does not suggest a bearish signal. Monitor for any larger-scale insider transactions in the coming weeks, but this cluster alone warrants no action. The mixed earnings report remains the more relevant near-term catalyst.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
TEVA ▲ +1.72% at T+20d
NEUTRAL call ✓ call won +1.72% · α vs SPY +2.63% · entry $36.14 → $36.76
Next anchor: T+60d in 5w
Latest observation: T+34 +12.84% FF3 residual α
Entry anchored
Aug 10, 05:43 AM ET
via 1-min bar
T+1d
+0.94%
call +0.94% · α +1.26%
$36.48
settled 7w ago
T+5d
+0.89%
call +0.89% · α +0.93%
$36.46
settled 7w ago
T+20d
+1.72%
call +1.72% · α +2.63%
$36.76
settled 24d ago
T+60d
—
call — · α —
—
in 5w

Price Chart

Loading chart...

Executive Summary

Three Teva insiders sold a combined $1.34M in shares over the past week, representing 0.003% of the $41.2B market cap — a trivial amount. The sales occurred shortly after Teva's Q2 earnings release (mixed results: revenue -1% YoY, EPS miss, but strong innovative brand growth and maintained guidance). The dollar value is too small to carry any informational signal.

Key Financial Metrics

Direction
selling
Total Value
$1.3M
Insiders
3

Key Facts

  • Three insiders sold shares: Eric A. Hughes (25.6K shares, $892K), Placid Jover (12.8K shares, $447K), and Tal Zvi Zaks (17 shares, $593)
  • Total selling value of $1.34M is 0.003% of Teva's $41.2B market cap
  • Sales occurred on 2026-08-03 and 2026-08-05, following the Q2 2026 earnings release on 2026-07-29
  • Q2 earnings showed revenue of $4.14B (-1% YoY) and non-GAAP EPS of $0.02, below consensus of $0.05

Financial Impact

Insider selling of $1.34M is negligible relative to market cap of $41.2B (<0.01%)

dilutioninsider holdings

Risk Factors

  • No material risk from this cluster due to negligible dollar amounts
  • If insiders increase selling volume significantly, it could signal a change in sentiment

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TEVA-1786356496894
31 reports for TEVA
Performance horizon
100% Hit rate 9 of 9 directional calls best @ T+20▲ +17.61%Jul 20, 2026
Filters
Rows
Reports for TEVA — sortable, filterable
TypeNow
Sep 10, 2026
22d ago
Press Release
NEUTRAL ★ 5/10
$36.35 $39.19▲ +7.81%▲ +8.31%$39.29 (+8.09%)
Sep 8, 2026
24d ago
424B5
NEUTRAL ★ 5/10
$36.76 $39.25▲ +6.77%▲ +7.89%$39.29 (+6.88%)
Sep 2, 2026
4w ago
Court Ruling
NEUTRAL ★ 1/10
$37.49 $36.35▼ −3.04%▼ −2.08%$39.29 (+4.80%)
Aug 28, 2026
5w ago
Press Release
BULLISH ★ 6/10
$36.44 $36.36▼ −0.22%▼ −0.33%$39.29 (+7.82%)
Aug 25, 2026
5w ago
Court Ruling
NEUTRAL ★ 2/10
$38.10 $36.20▼ −4.99%▼ −4.46%$39.29 (+3.12%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$38.10 $36.20▼ −4.99%▼ −4.46%$39.29 (+3.12%)
Aug 10, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$36.14 $36.46▲ +0.89%▲ +0.93%$39.29 (+8.72%)
Aug 5, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$34.81 $36.45▲ +4.70%▲ +3.49%$39.29 (+12.87%)
Jul 31, 2026
9w ago
Court Ruling
BULLISH ★ 7/10
$35.01 $35.36▲ +1.00%▼ −2.51%$39.29 (+12.23%)
Jul 29, 2026
9w ago
8-K
MIXED ★ 5/10
$34.71 $34.72▲ +0.03%▼ −5.50%$39.29 (+13.20%)
Showing 10 of 31

US Market Status

Market Open — Closes in 3h 40m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 10, 2026